CONCLUSION:
We present the first prediction model for histopathological adenomyosis
diagnosis. In future, this tool can be useful for both patients and
clinicians, with a potential to reduce morbidity and to contribute to
shared decision making. Since patient management depends on several
factors, such as age, symptoms, and comorbidity, the clinical use of the
predicted risks from the proposed model should still be decided on an
individual basis. Thus, before steps are made for use in clinical
practise, external validation of the model is needed.
CONFLICTS OF INTEREST: None of the authors have any relevant
conflicts of interest to disclose.